Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Amedisys Inc (DE:ADY)
FRANKFURT:ADY
Holding DE:ADY?
Track your performance easily
ADY Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€81.00 - €89.50
Previous Close€86.5
Volume0.00
Average Volume (3M)100.00
Market Cap
€2.88B
Enterprise Value€3.23B
Total Cash (Recent Filing)$149.90M
Total Debt (Recent Filing)$474.64M
Price to Earnings (P/E)―
Beta0.07
Next Earnings
Oct 29, 2024EPS Estimate
€1.06Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding32,740,584
10 Day Avg. Volume0
30 Day Avg. Volume100
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)2.52
Price to Sales (P/S)1.38
Price to Cash Flow (P/CF)15.10
P/FCF Ratio14.10
Enterprise Value/Market CapN/A
Enterprise Value/Revenue2.78
Enterprise Value/Gross Profit3.26
Enterprise Value/Ebitda19.59
Forecast
1Y Price Target
€92.30Price Target Upside6.70% Upside
Rating ConsensusHold
Number of Analyst Covering3
Amedisys News
PremiumCompany Announcements
Amedisys CIO Michael North Exits with $3M Severance Package
PremiumCompany Announcements
Amedisys Releases Q2 Supplemental Financial Slides
Bulls Say, Bears Say
Bulls Say
AcquisitionFriday's announcement meaningfully increases the likelihood of the AMED sale to UNH closing in the next few months.
DivestitureAmedisys' recent divestiture of certain home health assets signals progress towards the Optum for AMED deal closure.
Earnings2Q24A results came in above consensus estimates and the analyst's model.
Bears Say
AcquisitionAnother bidder willing to pay a similar or greater price fails to emerge if the proposed acquisition by Optum does not close.
Analyst RatingAnalyst downgrades the stock to Hold.
Deal ClosureDownside risks to the rating and price target include the failure of the deal closing.
---
Options Prices
Currently, No data available
---
Ownership Overview
2.15% Insiders
23.53% Mutual Funds
<0.01% Other Institutional Investors
49.74% Public Companies and
Individual Investors
ADY FAQ
What was Amedisys Inc’s price range in the past 12 months?
Amedisys Inc lowest stock price was €81.00 and its highest was €89.50 in the past 12 months.
What is Amedisys Inc’s market cap?
Currently, no data Available
When is Amedisys Inc’s upcoming earnings report date?
Amedisys Inc’s upcoming earnings report date is Oct 29, 2024 which is in 18 days.
How were Amedisys Inc’s earnings last quarter?
Amedisys Inc released its earnings results on Jul 24, 2024. The company reported €1.202 earnings per share for the quarter, beating the consensus estimate of €1.077 by €0.125.
Is Amedisys Inc overvalued?
According to Wall Street analysts Amedisys Inc’s price is currently Undervalued.
Does Amedisys Inc pay dividends?
Amedisys Inc does not currently pay dividends.
What is Amedisys Inc’s EPS estimate?
Amedisys Inc’s EPS estimate is €1.06.
How many shares outstanding does Amedisys Inc have?
Amedisys Inc has 32,740,585 shares outstanding.
What happened to Amedisys Inc’s price movement after its last earnings report?
Amedisys Inc reported an EPS of €1.202 in its last earnings report, beating expectations of €1.077. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Amedisys Inc?
Among the largest hedge funds holding Amedisys Inc’s share is Highbridge Capital Management LLC. It holds Amedisys Inc’s shares valued at 30M.
---
Amedisys Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
€92.30 (6.70% Upside)
€92.30 (6.70% Upside)
Blogger Sentiment
Bearish
DE:ADY Sentiment 100%
Sector Average 70%
Sector Average 70%
Technicals
SMA
Positive
20 days / 200 days
Momentum
4.04%
12-Months-Change
Fundamentals
Return on Equity
8.63%
Trailing 12-Months
Asset Growth
6.81%
Trailing 12-Months
Company Description
Amedisys Inc
Amedisys, Inc. engages in the provision of healthcare services. It operates through the following business segments: Home Health, Hospice, and Personal Care. The Home Health segment delivers services in the homes of individuals who may be recovering from an illness, injury, or surgery. The Hospice segment provides care that is designed to provide comfort and support for those who are facing a terminal illness. The Personal Care segment gives patients assistance with the essential activities of daily living. The company was founded by William F. Borne in 1982 and is headquartered in Baton Rouge, LA.
---
ADY Company Deck
---
ADY Earnings Call
Q4 2023
0:00 / 0:00
---
ADY Stock 12 Month Forecast
Average Price Target
€92.30
▲(6.70% Upside)
Technical Analysis
Best Analysts Covering ADY
1 Year
1 Year Success Rate
3/8 ratings generated profit
1 Year Average Return
-11.38%
reiterated a buy rating 7 months ago
Copying Ben Hendrix's trades and holding each position for 1 Year would result in 37.50% of your transactions generating a profit, with an average return of -11.38% per trade.
---